Allan Bombard, MD
Chief Medical Officer; Sharp Mary Birch Hospital for Women
Allan Bombard, MD. is Chief Medical Officer at Sharp Mary Birch Hospital in San Diego, California, the largest women's hospital in the western United States. Previously Dr. Bombard was the chair of Obstetrics and Gynecology at Lutheran Medical Center, and he has served as Western US Medical Director for Women's Health at Aetna US Healthcare. He holds the rank of Professor at the Albert Einstein College of Medicine and the State University of New York at Downstate Medical Center. Dr. Bombard is an established leader who has worked to bridge the fields of Ob/Gyn and genetics, improving and increasing access to healthcare services.
Dr. Bombard is board-certified in both clinical genetics and obstetrics/gynecology. He received his Bachelor of Arts from Colgate University and his Doctor of Medicine from the George Washington University. He completed a residency in Ob/Gyn at the Wilford Hall USAF Medical Center in San Antonio, Texas, and his fellowship in Human Genetics at Northwestern University. Dr. Bombard retired from the USAF Reserves in 2002 with the rank of Colonel, and served in Operation Desert Storm. He is a Founding Fellow of the American College of Medical Genetics (ACMG), a Fellow of the American College of Obstetricians & Gynecologists (ACOG), and a life member of the American College of Physician Executives (ACPE). He has lectured extensively on a variety of women's health issues including genetic counseling, prenatal screening and diagnosis, the business of medicine, and BRCA screening. His articles have appeared in peer-reviewed medical journals such as the Lancet and the American Journal of Obstetrics & Gynecology.
In California we deliver more babies each year than any other state in the nation. It is my hope that the CMQCC will broadly implement quality assessments and other outcome indicators, moving current standards from simple administrative data points to clinically meaningful measures that will directly improve the quality of care that our patients receive. We have the opportunity to lead the nation in crafting real clinical measures that are both useful in assessing quality and will improve the care in our communities.
